Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

BACKGROUND: Because multiple sclerosis (MS) is a chronic disease causing disability over decades, it is crucial to know if the short-term effects of disease-modifying therapies reported in randomised controlled trials reduce long-term disability. This 10-year prospective observational study of disab...

Descripción completa

Detalles Bibliográficos
Autores principales: Palace, Jacqueline, Duddy, Martin, Lawton, Michael, Bregenzer, Thomas, Zhu, Feng, Boggild, Mike, Piske, Benjamin, Robertson, Neil P, Oger, Joel, Tremlett, Helen, Tilling, Kate, Ben-Shlomo, Yoav, Lilford, Richard, Dobson, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518464/
https://www.ncbi.nlm.nih.gov/pubmed/30242090
http://dx.doi.org/10.1136/jnnp-2018-318360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518464/
https://www.ncbi.nlm.nih.gov/pubmed/30242090
http://dx.doi.org/10.1136/jnnp-2018-318360

Ejemplares similares